A novel application of dorsal window chambers: Repetitive imaging of tumor-associated lymphatics

Microvascular Research

Volumn 83, Issue 3, 2012, Pages 360-365

  Gaustad, Jon Vidar ^a   Simonsen, Trude G ^a   Leinaas, Marit N ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; TETRAMETHYLRHODAMINE;

ANALYTICAL EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DORSAL WINDOW CHAMBER; FEMALE; HUMAN; HUMAN CELL; ILLUMINATION; LYMPH VESSEL; LYMPHANGIOGRAPHY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; VASODILATATION;

ANIMALS; CELL LINE, TUMOR; DEXTRANS; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; LYMPHOGRAPHY; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; RHODAMINES; TIME FACTORS;

EID: 84859495481     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.02.003     Document Type: Article

References (21)

1. Brurberg K.G., Gaustad J.V., Mollatt C.S., Rofstad E.K. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia 2008, 10:727-735.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
3. Enholm B., Karpanen T., Jeltsch M., Kubo H., Stenback F., Prevo R., Jackson D.G., Yla-Herttuala S., Alitalo K. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 2001, 88:623-629.
4. Gaustad J.V., Brurberg K.G., Simonsen T.G., Mollatt C.S., Rofstad E.K. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 2008, 10:354-362.
5. Gombos Z., Xu X., Chu C.S., Zhang P.J., Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin. Cancer Res. 2005, 11:8364-8371.
6. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., Alitalo K. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 2005, 65:4739-4746.
7. Hoshida T., Isaka N., Hagendoorn J., di T.E., Chen Y.L., Pytowski B., Fukumura D., Padera T.P., Jain R.K. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006, 66:8065-8075.
8. Huang J., Frischer J.S., Serur A., Kadenhe A., Yokoi A., McCrudden K.W., New T., O'Toole K., Zabski S., Rudge J.S., Holash J., Yancopoulos G.D., Yamashiro D.J., Kandel J.J. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7785-7790.
9. Isaka N., Padera T.P., Hagendoorn J., Fukumura D., Jain R.K. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res. 2004, 64:4400-4404.
10. Jain R.K., Munn L.L., Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2002, 2:266-276.
11. Ji R.C. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006, 25:677-694.
12. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009, 21:154-165.
13. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 2000, 156:1499-1504.
14. Padera T.P., Kadambi A., di T.E., Carreira C.M., Brown E.B., Boucher Y., Choi N.C., Mathisen D., Wain J., Mark E.J., Munn L.L., Jain R.K. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
15. Padera T.P., Kuo A.H., Hoshida T., Liao S., Lobo J., Kozak K.R., Fukumura D., Jain R.K. Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol. Cancer Ther. 2008, 7:2272-2279.
16. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer 1994, 70:804-812.
17. Rofstad E.K., Wahl A., Davies C.L., Brustad T. Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts. Cell Tissue Kinet. 1986, 19:205-216.
18. Rubbia-Brandt L., Terris B., Giostra E., Dousset B., Morel P., Pepper M.S. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin. Cancer Res. 2004, 10:6919-6928.
19. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7:192-198.
20. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001, 7:186-191.
21. Sulkes A. Novel multitargeted anticancer oral therapies: sunitinib and sorafenib as a paradigm. Isr. Med. Assoc. J. 2010, 12:628-632.